Clinical Trial Update: Heparin Based on Ideal Body Weight for Cardiopulmonary Bypass in Obese Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating heparin dosing based on ideal body weight for cardiopulmonary bypass in obese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Heparin (unfractionated heparin)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Cardiac Surgery, Cardiopulmonary Bypass | Phase 4 | Status: COMPLETED